>:5@JKH@=%^ECL=3KJ%QQ/G9O>|*,C
SYSTEM PROCESSING...
>:5@JKH@=%^ECL=3KJ%QQ/G9O>|*,C
SYSTEM PROCESSING...
Posted: 2025-04-16 23:06:42 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-16 23:07:03 UTC
Verified By
Rollup News
The NEJM article and editorial discuss extended reduced-dose apixaban for cancer-associated venous thromboembolism (VTE).
Extended reduced-dose apixaban
Cancer-associated venous thromboembolism (VTE)
Noninferiority of reduced-dose apixaban